Shanghai C&D INNOSTIC Medical Technology Group Co., Ltd. (SHE:301584)
China flag China · Delayed Price · Currency is CNY
21.12
-0.38 (-1.77%)
Sep 2, 2026, 4:00 PM EDT

SHE:301584 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,5981,8561,7881,4871,051577.97
Trading Asset Securities
-70.81----
Cash & Short-Term Investments
1,5981,9271,7881,4871,051577.97
Cash Growth
-10.64%7.75%20.24%41.54%81.80%-15.22%
Accounts Receivable
8,7618,0626,5936,1525,3925,141
Other Receivables
199.38132.77142.83145.8175.31.48
Receivables
8,9618,1956,7366,2985,4685,142
Inventory
3,3483,4473,4792,5131,8411,229
Prepaid Expenses
-0.20.11---
Other Current Assets
817.57651.17593.05448.18419430.07
Total Current Assets
14,72414,22012,59610,7468,7787,379
Property, Plant & Equipment
255.55270.14289.54236.6135.71104.07
Goodwill
37.3137.3140.240.237.3137.31
Other Intangible Assets
7.417.135.737.337.377.92
Long-Term Accounts Receivable
-14.3622.2214.254.1423.44
Long-Term Deferred Tax Assets
99.62101.980.0572.0169.6248.46
Long-Term Deferred Charges
74.6782.8575.9946.8119.964.47
Other Long-Term Assets
19.7718.952.748.264.5-
Total Assets
15,21814,75213,11211,1719,0577,605

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
8,1937,8176,3155,2304,5624,829
Accrued Expenses
71.07279.06217.45209.15177.39150.72
Short-Term Debt
3,4393,4593,8543,5282,3881,027
Current Portion of Long-Term Debt
19.6423.246.29--154.06
Current Portion of Leases
-44.5251.94--24.51
Current Income Taxes Payable
112.6537.4934.4632.0228.8326.47
Current Unearned Revenue
493.87418.65558.46405.48414.89182.06
Other Current Liabilities
282.85149.09166.07201.25177.4586.37
Total Current Liabilities
12,61212,22811,2439,6067,7496,481
Long-Term Debt
--23.1869.53115.8889.22
Long-Term Leases
76.4960.7968.6863.1248.1627.94
Long-Term Unearned Revenue
0.1-0.010.05--
Long-Term Deferred Tax Liabilities
0.240.270.631.280.020.47
Other Long-Term Liabilities
----1.2113.97
Total Liabilities
12,68912,28911,3359,7407,9146,612

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
421.29421.29358.1358.1358.1358.1
Additional Paid-In Capital
327.62345.238.2336.7131.3626.28
Retained Earnings
1,4201,3551,085856.59660.29557.63
Total Common Equity
2,1692,1211,4811,2511,050942.01
Minority Interest
361.02342.16295.37179.9592.7350.94
Shareholders' Equity
2,5302,4631,7771,4311,142992.95
Total Liabilities & Equity
15,21814,75213,11211,1719,0577,605

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
3,5353,5884,0443,6612,5521,323
Net Cash (Debt)
-1,937-1,661-2,256-2,174-1,501-744.9
Net Cash Growth
------
Net Cash Per Share
-4.84-4.37-6.32-6.09-4.22-2.10
Filing Date Shares Outstanding
434.52421.29358.1356.92355.67358.1
Total Common Shares Outstanding
434.52421.29358.1356.92355.67358.1
Working Capital
2,1121,9921,3531,1401,029898.88
Book Value Per Share
4.995.034.143.512.952.63
Tangible Book Value
2,1242,0771,4351,2041,005896.78
Tangible Book Value Per Share
4.894.934.013.372.832.50
Buildings
-43.6345.3345.3345.3345.33
Machinery
-229.64192.42116.8635.614.13
Construction In Progress
-0.91.411.13-1.54